BioCentury
ARTICLE | Financial News

Flex Pharma files for IPO

December 30, 2014 2:32 AM UTC

Neurology play Flex Pharma Inc. (Boston, Mass.) filed to raise up to $60 million in an IPO on NASDAQ underwritten by Jefferies; Piper Jaffray; JMP; Cantor Fitzgerald; and Roth Capital.

Flex said it intends to start at least one proof-of-concept study in 2Q15 of its lead program to treat nocturnal leg cramps under an approval pathway for dietary supplements. Pending results of that study, Flex plans to conduct a Phase II trial and seek approval of the candidate as a pharmaceutical product. ...